Abstract

Introduction: Hemangiomas that have undergone involution, also have a risk for the formation of residual scar tissue or scar, as well as hemangiomas undergoing excision therapy. Scar, especially those that occur in areas that are visible or open, certainly has implications for the patient's quality of life. This study aimed to determine the level of satisfaction of hemangioma patients who received propranolol therapy with excision therapy based on the scar results at Dr. Mohammad Hoesin General Hospital, Palembang, Indonesia.
 Methods: Cross-sectional analytic observational study. A total of 95 research subjects participated in this study. The level of satisfaction is based on the severity of the lesion scar. The family assessment was assessed using a Likert scale consisting of the following assessment items itching, pain, color, thickness, and shape. Data analysis was carried out with the help of SPSS version 25 in univariate and bivariate.
 Results: Research subjects who received propranolol therapy had different levels of satisfaction from research subjects who received surgical therapy. Research subjects who received propranolol therapy had a higher satisfaction level of 1.71 higher than those who received surgical therapy.
 Conclusion: There are differences in the level of satisfaction of hemangioma patients who received propranolol therapy with excision therapy based on the scar results at Dr. Mohammad Hoesin General Hospital, Palembang, Indonesia.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.